Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.530
0.00 (0.00%)
Nov 21, 2024, 11:37 AM EST - Market open
Cardiff Oncology Employees
As of December 31, 2023, Cardiff Oncology had 32 total employees, including 31 full-time and 1 part-time employees. The number of employees increased by 6 or 23.08% compared to the previous year.
Employees
32
Change (1Y)
6
Growth (1Y)
23.08%
Revenue / Employee
$21,500
Profits / Employee
-$1,343,906
Market Cap
129.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Puma Biotechnology | 185 |
Cabaletta Bio | 103 |
Compugen | 68 |
Candel Therapeutics | 42 |
Zentek | 24 |
Avalo Therapeutics | 19 |
Inhibikase Therapeutics | 9 |
Context Therapeutics | 5 |
CRDF News
- 21 days ago - Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC - GlobeNewsWire
- 6 weeks ago - Cardiff Oncology: Paramount Data Imminent In Huge First-Line mCRC Market - Seeking Alpha
- 3 months ago - Cardiff: Second Half Of 2024 mCRC Data Is Major Inflection Point - Seeking Alpha
- 3 months ago - Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Cardiff Oncology to Present at the Jefferies Healthcare Conference - GlobeNewsWire
- 6 months ago - Cardiff Oncology's Onvansertib: A Speculative Buy With Promising Data - Seeking Alpha
- 6 months ago - Cardiff Oncology to Present at Upcoming Investor Conferences in May - GlobeNewsWire
- 7 months ago - Cardiff Oncology, Inc. (CRDF) Q1 2023 Earnings Call Transcript - Seeking Alpha